Technology Wire Cambodia
SEE OTHER BRANDS

Hottest science and technology news from Cambodia

Press Releases

Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on Technology Wire Cambodia.

Teva and Alvotech Announce FDA Approval of Interchangeability for SELARSDI™ (ustekinumab-aekn) with Stelara® (ustekinumab)
U.S. Stocks End Midweek in Green on Nvidia’s Historic Surge
NewGenIVF Introduces NewGenSort to Support Men’s Reproductive Health Across Asia
Electric and Luxury Vehicle Market Outlook, Innovation, Demand Shifts and Market Leaders | Exactitude Consultancy
Transcript of Minister for Foreign Affairs Dr Vivian Balakrishnan’s Keynote Dialogue at Singapore Institute of International Affairs’ 17th ASEAN and Asia Forum, 5 August 2025
HR Asia Best Companies to Work for in Asia is Redesigning Work to Keep People, Skills, and Generations Together in Vietnam
Alvotech Meeting Investors and Participates in Fireside Chat At Barclays 27th Global Healthcare Conference in Miami, Florida
NewGenIVF Announces Reverse Stock Split
Ambient Commerce Market to grow steadily at 25.92% CAGR through 2034 to USD 319.61 Billion
Agricultural Mapping and Imaging Market Set to Reach USD 10.79 Billion by 2034, Expanding at a CAGR of 8.34%
NewGen Filed 2024 Annual Report on Form 20-F
Alvotech and Teva Announce Filing Acceptance of U.S. Biologics License Application for AVT06, a Proposed Biosimilar to Eylea® (aflibercept)
Alvotech and Teva Announce Filing Acceptance of U.S. Biologics License Application for AVT06, a Proposed Biosimilar to Eylea® (aflibercept)
Bitget Joins UNICEF Game Changers Coalition to Provide Blockchain Education to 300K People in 2025
2025 July- Navigating Talent Trends in Myanmar
Alvotech Reports Record Results for 2024 and Provides Business Update
Alvotech and Teva Announce Filing Acceptance of U.S. Biologics License Applications for AVT05, a Proposed Biosimilar to Simponi® and Simponi Aria® (golimumab)
Alvotech and Teva Announce Filing Acceptance of U.S. Biologics License Applications for AVT05, a Proposed Biosimilar to Simponi® and Simponi Aria® (golimumab)
NewGen Secures Strategic Funding to Drive International Expansion and Corporate Growth
NewGenIVF Announces Termination of Proposed Reverse Merger Transaction with European Wellness

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions